Joint Formulary & PAD

Phenylephrine hydrochloride and tropicamide - Mydriasis

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Ophthalmic insert
Associated Icons :
Restrictions / Comments :
Important
MYDRIASERT 5.4mg/0.28mg Ophthalmic Insert

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Phenylephrine hydrochloride and tropicamide
Indication :
Mydriasis
Group Name :
Keywords :
Brand Names Include :
Mydriasert
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Phenylephrine hydrochloride and tropicamide is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Mydriasis.

Committee Recommendations (1)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.